Atlas Trials

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

Clinical trial NCT02932878 · COMPLETED

Trial details

NCT number
NCT02932878
Sponsor
Sun Pharmaceutical Industries, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2016-09-02
Primary completion
2017-04-10
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.